United Parcel Service, Inc. : Statement by UPS Spokesperson Kara Gerhardt Ross
06/26/2012| 08:50pm US/Eastern
Recommend:
As a member of the Pharmaceutical Distribution Security Alliance (PDSA),
UPS applauds Congress for the passage of the Prescription Drug User Fees
Authorization bill. The legislation is integral to ensuring the Food and
Drug Administration (FDA) has the necessary resources to review new
treatments that allow patients to receive the medicine they need to live
longer healthier lives.
However, a very important safety proposal that was close to agreement
did not get included in the final bill. The "Track and Trace Proposal,"
supported by PDSA would have provided a bipartisan national 50-state
solution to supply chain safety for medicines. The current patchwork of
state regulations and varying individual license requirements is an
impediment to law enforcement and protecting patients. A national system
would help to ensure safe passage of drugs and medical products across
the U.S. and address the growing problem of counterfeit drugs through
the complex network of manufacturers, wholesalers, third party logistics
providers and pharmacies.
Senators Bennet and Burr and Representatives Bilbray and Matheson, who
respectively co-authored the track and trace proposals, deserve credit
for their leadership and commitment to shepherding supply chain safety
in healthcare.
We understand that the industry, the FDA, The Pew Charitable Trust and
congressional leaders were close to agreement on the proposal and we
urge them to continue to work to get it done this session to provide a
50-state solution that protects U.S. consumers.
UPS
Kara Ross, 703-362-6046
karaross@ups.com
© Business Wire 2012
Recommend :
